Galacto-Oligosaccharides (GOS) Market size will witness a substantial boom during the period 2021 to 2027 due to the rising instances of chronic disorders and the growing consumption of confectionery products. The rapidly increasing infant population has bolstered the higher intake of baby formula. The changing taste preferences coupled with the increasing concerns over immune health and gut development will contribute towards the growth of the market.
The continuously rising R&D investments and the globally expanding health-conscious population are other factors influencing the industry expansion.
On the basis of form, the galacto-oligosaccharides market size from the syrup segment is expected to see considerable prominence with increasing usage in cooking as sweeteners. This product is extensively employed on account of its excellent dissolving characteristics. GOS in the syrup form is also used to treat stomach disorders like constipation as well as to prevent allergies in infants. Rising adoption across dietary supplements and dairy products will lead to market growth.
In terms of source, the GOS market is classified into plants, animals, and microorganisms. Among these, the plant segment will garner notable proceeds through 2027. This can be attributed to their ease of generation from certain root vegetables and beans. The booming lactose intolerant population base is another significant contributor to the industry expansion.
With regards to function, prebiotics will emerge as a lucrative segment for the galacto-oligosaccharides industry owing to the rising need for developing favorable microorganisms in the colon. As GOS passes undigested into the colon, it enhances the bowel mass, which in turn promotes the growth of certain beneficial bacteria.
Application wise, the food & beverages sector is anticipated to collect substantial gains for the GOS market driven by the increased intake of dairy products, like cheese. The rising obligation for convenience foods has made way for the higher consumption of soups, sauces, and pastries. Growing investments and the surging need for low calorie and sweetened food given the prevalence of sedentary lifestyles will massively drive the market outlook.
Based on regional segmentation, Europe Galacto-oligosaccharides industry is set to gain traction on account of the growing infant population and the rising intake of ready-to-eat meals in the region. The mount in the number of patients affected by diabetes and blood pressure ailments has triggered the higher consumption of dietary supplements. Surging household incomes of individuals has given rise to the increasing preference for beverages and confectionery products by regional consumers. The jump in the number of old-aged individuals will also add positive impetus to the industry growth.
The galacto-oligosaccharides market constitutes the presence of prominent players such as Nissin Sugar, Frieslandcampina (Zuivelcooperatie FrieslandCampina U.A.), Kerry Group, Samyang (Jeon Jung Yoon), Clasado BioSciences, Ingredion, and Yakult Pharmaceutical Industry.
Strategic marketing initiatives, like partnerships, mergers, investments, acquisitions and new product developments are some prominent measures undertaken by these firms to reinforce their position in the business landscape.
For instance, in February 2021, Clasado Biosciences announced that British Rowing had turned the official supplier for Bimuno Travelaid, its prebiotic supplement. The product deploys non-digestible galactooligosaccharides (GOS) technology to support a balanced gut in rowing athletes while traveling.
In another instance, in April 2020, FrieslandCampina Ingredients became a part of the Global Prebiotic Association (GPA), to extend its offerings of prebiotics with well-researched GOS and 2'FL.
The ongoing COVID-19 crisis called for an alarming impact on the global economy. It not only substantially impacted a gamut of industries across the world but also paved the way for personal life changes. However, the intake of galacto-oligosaccharides recorded a rise in demand in prebiotics to enhance the human gut microbiome, given the escalating COVID-19 infection count.